Wilhelm Bone
21Patents
3h-index
60Co-inventors
62Inventor score
Filing activity: Jul 7, 2010 → Aug 21, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9549932B2 | 2-(morpholin-4-yl)-1,7-naphthyridines | Chemistry; Metallurgy | 16 | Active |
| US8278469B2 | 17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseases | Chemistry; Metallurgy | 4 | Active |
| US9682974B2 | Heteroaryl substituted pyrazoles | Chemistry; Metallurgy | 4 | Active |
| US9765058B2 | Substituted benzylpyrazoles | Human Necessities | 3 | Active |
| US9993484B2 | 2-(morpholin-4-yl)-1,7-naphthyridines | Chemistry; Metallurgy | 3 | Active |
| US9745285B2 | Heteroaryl substituted pyrazoles | Chemistry; Metallurgy | 3 | Active |
| US10772893B2 | 2-(morpholin-4-yl)-1,7-naphthyridines | Chemistry; Metallurgy | 2 | Active |
| US9085603B2 | Progesterone receptor antagonists | Human Necessities | 2 | Active |
| US9717739B2 | 17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseases | Chemistry; Metallurgy | 2 | Active |
| US10155004B2 | 17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseases | Chemistry; Metallurgy | 2 | Active |
| US10350206B2 | Benzyl substituted indazoles as BUB1 inhibitors | Chemistry; Metallurgy | 1 | Active |
| US9109004B2 | Progesterone receptor antagonists | Human Necessities | 1 | Active |
| US10428044B2 | 3-amino-1,5,6,7-tetrahydro-4H-indol-4-ones | Chemistry; Metallurgy | 0 | Active |
| US9206219B2 | 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl derivatives, methods for the production thereof and the use thereof for treating diseases | Chemistry; Metallurgy | 0 | Active |
| US9102701B2 | 17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-diene-11-ethynylphenyl derivatives, methods for the production thereof and use thereof for treating diseases | Chemistry; Metallurgy | 0 | Active |
| US12227501B2 | 3-amino-2-[2-(acylamino)pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one as CSNK1 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11529356B2 | 2-(morpholin-4-yl)-1,7-naphthyridines | Chemistry; Metallurgy | 0 | Active |
| US8969328B2 | Progesterone receptor antagonists | General | 0 | Revoked |
| US9096640B2 | 17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-diene-11-methylene oxyalkylene aryl derivatives, process for preparation thereof, and use thereof for treatment of diseases | Human Necessities | 0 | Active |
| US10894784B2 | Heteroarylbenzimidazole compounds | Chemistry; Metallurgy | 0 | Active |
| US9156877B2 | 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzylidene derivatives, methods for the production thereof and use thereof for treating diseases | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.